Discovery Life Sciences Acquires ReachBio Research Labs

April 21, 2023

"We share Discovery's passion for science and believe that combining our expertise in cell-based assays and drug screening with Discovery's broad multi-omics capabilities will enable us to provide a....


ReachBio Partners with Swiss Biotech abc biopply

August 25, 2022

Seattle-based primary cell biology CRO ReachBio and Swiss biotech abc biopply announced today a partnership to jointly co-market their preclinical test models. The two companies plan to support their....

World ADC San Diego | September 6-9, 2022

August 18, 2022

AAI Annual Meeting, Immunology2022 | Portland, OR May 6-10

April 25, 2022

The ReachBio team is delighted to be returning to the Annual Meeting for The American Association of Immunologists next month in Portland, Oregon. Our CSO, Dr. Emer Clarke, will be presenting a....


World ADC London

March 20, 2020

March 2-5 2020 | London, UK


World ADC San Diego 2019

October 10, 2019

ReachBio is please to be participating in the 10th annual  World ADC San Diego conference as a select exhibitor. ReachBio is the only CRO providing toxicity assays that will be exhibiting at this....

ReachBio Featured on Sickle Cell Anemia News

August 27, 2019

An article referencing ReachBio's new drug screening platform to discover therapeutic compounds that trigger the production of fetal hemoglobin (HbF) to treat sickle cell disease (SCD) and other....

A Platform for Screening Drugs to Treat Sickle Cell Disease

August 13, 2019

SEATTLE, August 13, 2019  -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering a drug screening platform to....

ReachBio Offers ADC Off-target Toxicity & Linker Stability Services

July 22, 2019

SEATTLE, July 9, 2019 -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker....

Applied Pharmaceutical Toxicology 2019

April 25, 2019

Once again, ReachBio is excited to announce our continued sponsorship for the annual Applied Pharmaceutical Toxicology (APT) Conference  in South San Francisco, California. This year's event will....

SOT 58th Annual Meeting and ToxExpo

March 08, 2019

ReachBio will be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 58th Annual Meeting in Baltimore, Maryland. Stop by our booth, #4121, to learn about our latest assays to help....


Applied Pharmaceutical Toxicology 2018

April 10, 2018

ReachBio is excited to announce that we are slated to sponsor this year's Applied Pharmaceutical Toxicology (APT) Conference  in Boston, Massachusettsat the Merck Research Laboratories, May 15th....

SOT 57th Annual Meeting and ToxExpo

February 28, 2018

ReachBio will be returning to and exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 57th Annual Meeting in San Antonio, Texas. Our booth, #1631, will display a range of....


ReachBio Offers NK (V158+) Cells Optimized for ADCC Assays online

May 09, 2017

SEATTLE, May 9, 2017 -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering sourced, enriched and tested primary....

ReachBio's Chaney, talks cellPrism® and growth with CEOCFO Magazine

April 24, 2017

Rob Chaney, Co-Founder, COO & General Manager

Applied Pharmaceutical Toxicology 2017

April 17, 2017

We're excited to announce we'll be exhibiting at this year's Applied Pharmaceutical Toxicology (APT) Conference  in San Francisco, California at Genentech in building 35, May 15th - 17th.

SOT 56th Annual Meeting and ToxExpo

February 15, 2017

We are pleased to announce that ReachBio will be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth,  number 1616, will display....

ReachBio Research Labs Launches a New Drug Development Platform, cellPrism®

January 31, 2017

SEATTLE, Jan. 31, 2017 /PRNewswire/ -- ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to....


Human PBMCs Available Online

June 20, 2016

ReachBio Research Labs now makes it easy for you to purchase Human Peripheral Blood Mononuclear Cells (PBMCs) online! The blood that is used to make our primary cell products is obtained from healthy....

World Preclinical Congress 2016

June 01, 2016

Join us June 15th through the 17th, 2016 at the 15th Annual World Preclinical Congress in Boston, MA! Stop by booth #207, and meet our CSO, Dr. Emer Clarke, and Lead Scientist, Gary dos Santos. 

Society of Toxicology 55th Annual Meeting and ToxExpo

March 04, 2016

The Society of Toxicology 55th Annual Meeting and ToxExpo is next week! ReachBio will be exhibiting at the ToxExpo from March 14th through the 16th. We welcome all to stop by our booth #1300 to talk....


Happy New Year from ReachBio Research Labs!

December 31, 2015

It has been a good year for growth at ReachBio Research Labs! We have really appreciated working with our existing clients who have come back, time after time with new contract services. We have....

Thank you for visiting us at ACT 2015!

November 12, 2015

Thank you to everyone who took the time to visit with us at the American College of Toxicology (ACT) 2015 36th Annual Meeting, this week. We had a great time, and look forward to seeing everyone,....


Effects of Compounds on Thrombopoiesis: Beyond the CFU-Mk Colony Assay

September 11, 2014

The colony forming unit-megakaryocyte assay, better known as the CFU-Mk assay is a robust and predictive in vitro assay for evaluating the toxicity of test compounds on megakaryocytic progenitors.....

Hemotoxicity Testing: Predictive Lineage-Specific In Vitro Assay Services

May 12, 2014

If your drug development program has a particular lineage-specific hemotoxicity issue such as neutropenia (myeloid lineage toxicity), acute anemia (erythroid lineage toxicity) or thrombocytopenia....

ReachBio's Posters Presented at SOT 2014 Are Now Available to Download

April 10, 2014

Interested in in vitro assays to assess the risk of cytokine storms? Or in vitro evaluation of compound effects on leukemic progenitors vs normal progenitors? So are we!

Society Of Toxicology 2014

February 27, 2014

SOT 2014 Posters Available for Download!

ReachBio Research Labs presented the following posters at the recent Society of Toxicology conference in Phoenix, AZ. Click on the title to download a copy.